Gelonghui November 13th 丨According to the latest equity disclosure data from the Stock Exchange, on November 6, 2023, Zaiding Pharmaceutical (09688.HK) received JPMorgan Chase & Co. to increase its holdings by 2,652,400 shares at an average price of HK$21.9865 per share, involving approximately HK$583.173 million.
After increasing its holdings, the latest number of positions held by JPMorgan Chase & Co. was 120,744,604 shares, and the position ratio increased from 11.94% to 12.21%.
